Gaia Mancuso

Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes

Marco Lanzillotta, Corrado Campochiaro, Gaia Mancuso et al. · Lara D. Veeken · 2020 · 93 citations · Full text

Life Sciences, Immunology, Autoimmunity +6

Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study

Emanuel Della‐Torre, Marco Lanzillotta, Corrado Campochiaro et al. · European Journal of Internal Medicine · 2020 · 43 citations

Pharmacy, Immunology, Pharmacotherapy +7

Relationships between platelet counts, platelet volumes and reticulated platelets in patients with ITP: evidence for significant platelet count inaccuracies with conventional instrument methods

M. Diquattro, Fabio Gagliano, Giampiero Calabrò et al. · International Journal of Laboratory Hematology · 2009 · 23 citations

Medicine, Hematology, Pathology +7

Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease

Emanuel Della‐Torre, Marco Lanzillotta, Tommaso Germanò et al. · Seminars in Arthritis and Rheumatism · 2021 · 17 citations

Life Sciences, Internal Medicine, Autoimmunity +10

IgG4-Related Disease of the Oral Cavity. Case Series from a Large Single-Center Cohort of Italian Patients

Andrea Rampi, Marco Lanzillotta, Gaia Mancuso et al. · International Journal of Environmental Research and Public Health · 2020 · 16 citations · Full text

Dentistry, Oral Pathology, Oral Histology +10